Spread for Carinthian pharmaceutical company: 125 creditors worry about millions!

Spread for Carinthian pharmaceutical company: 125 creditors worry about millions!

Thörl-Maglern, Kärnten, Österreich - The Lukas Heil-Betriebsstätte GmbH from Thörl-Maglern, a pharmaceutical company that specializes in cancer therapy, is about to take a low point. An bankruptcy has been requested that affects 35 employees and 125 creditors. The debt amounts to a total of 6.93 million euros, such as The KURIER reports .

The company has difficulties because the production of the Cancer Medicine Isorel® was long in coming due to delays during pandemic and long approval processes. The product has only been in sales since May 2024, which is why the financial means for urgently needed marketing remained too low. The Lukas Foundation, which is behind the company, originally had the production of Isorel® as the goal and invested considerable resources in the construction of the highly specialized healing site. Nevertheless, the company heads for a renovation that provides a quota of 20 percent for creditors, as OE24 .

In the hope of an early rescue, Lukas Heil-Betriebstätstätte GmbH not only sought to resume the production of its medicinal products, but also to open up new business areas. This includes trade in drugs, the bottling of non-drugs and the development of clinical test preparations. The permits for these extensions are expected in April 2025. Despite the crisis, the company is optimistic and plans with a clear renovation concept.